Cargando…
The pressing questions in multiple sclerosis Care in the era of COVID-19
• MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308765/ https://www.ncbi.nlm.nih.gov/pubmed/32599294 http://dx.doi.org/10.1016/j.jns.2020.117005 |